{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:01:11Z","timestamp":1772136071238,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Program (IRP) of National Institute of Diabetes and Digestive and Kidney Diseases"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SARS-CoV-2 infection ranges from asymptomatic to severe with lingering symptomatology in some. This prompted investigation of whether or not asymptomatic disease results in measurable immune activation post-infection. Immune activation following asymptomatic SARS-CoV-2 infection was characterized through a comparative investigation of the immune cell transcriptomes from 43 asymptomatic seropositive and 52 highly exposed seronegative individuals from the same community 4\u20136 weeks following a superspreading event. Few of the 95 individuals had underlying health issues. One seropositive individual reported Cystic Fibrosis and one individual reported Incontinentia pigmenti. No evidence of immune activation was found in asymptomatic seropositive individuals with the exception of the Cystic Fibrosis patient. There were no statistically significant differences in immune transcriptomes between asymptomatic seropositive and highly exposed seronegative individuals. Four positive controls, mildly symptomatic seropositive individuals whose blood was examined 3 weeks following infection, showed immune activation. Negative controls were four seronegative individuals from neighboring communities without COVID-19. All individuals remained in their usual state of health through a five-month follow-up after sample collection. In summary, whole blood transcriptomes identified individual immune profiles within a community population and showed that asymptomatic infection within a super-spreading event was not associated with enduring immunological activation.<\/jats:p>","DOI":"10.1038\/s41598-021-83110-6","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:02:53Z","timestamp":1613818973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community"],"prefix":"10.1038","volume":"11","author":[{"given":"Hye Kyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Knabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Pipperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Volland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla A.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keunsoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sr.","given":"Ludwig","family":"Knabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romuald","family":"Bellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"G\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Walser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee","family":"von Laer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Hennighausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"83110_CR1","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"SF Pedersen","year":"2020","unstructured":"Pedersen, S. F. & Ho, Y. C. SARS-CoV-2: a storm is raging. J. Clin. Invest. 130, 2202\u20132205 (2020).","journal-title":"J. Clin. Invest."},{"key":"83110_CR2","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med 8, e46\u2013e47 (2020).","journal-title":"Lancet Respir. Med"},{"key":"83110_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"83110_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27, 883\u2013890 (2020).","journal-title":"Cell Host Microbe"},{"key":"83110_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"83110_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8511","author":"D Mathew","year":"2020","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. https:\/\/doi.org\/10.1126\/science.abc8511 (2020).","journal-title":"Science"},{"key":"83110_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 (2020).","journal-title":"Cell"},{"key":"83110_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","volume":"38","author":"RL Chua","year":"2020","unstructured":"Chua, R. L. et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 38, 970\u2013979 (2020).","journal-title":"Nat. Biotechnol."},{"key":"83110_CR9","doi-asserted-by":"publisher","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).","journal-title":"Sci. Immunol."},{"key":"83110_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842\u2013844 (2020).","journal-title":"Nat. Med."},{"key":"83110_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde, M. W. et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb. Mortal Wkly. Rep. 69, 993\u2013998 (2020).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"83110_CR12","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann, V. O. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265 (2020).","journal-title":"JAMA Cardiol."},{"key":"83110_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00230-w","author":"RM Ruggeri","year":"2020","unstructured":"Ruggeri, R. M., Campenni, A., Siracusa, M., Frazzetto, G. & Gullo, D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) https:\/\/doi.org\/10.1007\/s42000-020-00230-w (2020).","journal-title":"Hormones (Athens)"},{"key":"83110_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/jamainternmed.2020.3862","volume":"180","author":"S Lee","year":"2020","unstructured":"Lee, S. et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern Med 180, 1447 (2020).","journal-title":"JAMA Intern Med"},{"key":"83110_CR15","volume-title":"Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","author":"J He","year":"2020","unstructured":"He, J., Guo, Y., Mao, R. & Zhang, J. Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis (J. Med, Virol, 2020)."},{"key":"83110_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"JY Zhang","year":"2020","unstructured":"Zhang, J. Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107\u20131118 (2020).","journal-title":"Nat. Immunol."},{"key":"83110_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","volume":"107","author":"EG Thompson","year":"2017","unstructured":"Thompson, E. G. et al. Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis (Edinb.) 107, 48\u201358 (2017).","journal-title":"Tuberculosis (Edinb.)"},{"key":"83110_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13073-020-00823-5","volume":"13","author":"AC Aschenbrenner","year":"2021","unstructured":"Aschenbrenner, A. C. et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 13, 7 (2021).","journal-title":"Genome Med."},{"key":"83110_CR19","unstructured":"https:\/\/www.statista.com\/chart\/21699\/coronavirus-outbreak-in-ischgl\/."},{"key":"83110_CR20","doi-asserted-by":"crossref","unstructured":"Knabl, L. et al. High SARS-CoV-2 Seroprevalence in children and adults in the Austrian Ski Resort Ischgl. medRxiv, 2020.08.20.20178533 (2020).","DOI":"10.1101\/2020.08.20.20178533"},{"key":"83110_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139834","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.139834 (2020).","journal-title":"JCI Insight"},{"key":"83110_CR22","unstructured":"https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"83110_CR23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016-1035.e19 (2020).","journal-title":"Cell"},{"key":"83110_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200\u20131204 (2020).","journal-title":"Nat. Med."},{"key":"83110_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","volume":"21","author":"D Peckham","year":"2020","unstructured":"Peckham, D., McDermott, M. F., Savic, S. & Mehta, A. COVID-19 meets cystic fibrosis: for better or worse?. Genes Immunol 21, 260\u2013262 (2020).","journal-title":"Genes Immunol"},{"key":"83110_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","volume":"19","author":"R Cosgriff","year":"2020","unstructured":"Cosgriff, R. et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J. Cyst. Fibros 19, 355\u2013358 (2020).","journal-title":"J. Cyst. Fibros"},{"key":"83110_CR27","doi-asserted-by":"publisher","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","volume":"170","author":"P Mondejar-Lopez","year":"2020","unstructured":"Mondejar-Lopez, P. et al. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey. Respir. Med. 170, 106062 (2020).","journal-title":"Respir. Med."},{"key":"83110_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41574-020-0364-6","volume":"16","author":"N Stefan","year":"2020","unstructured":"Stefan, N., Birkenfeld, A. L., Schulze, M. B. & Ludwig, D. S. Obesity and impaired metabolic health in patients with COVID-19. Nat. Rev. Endocrinol. 16, 341\u2013342 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"83110_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13128","author":"BM Popkin","year":"2020","unstructured":"Popkin, B. M. et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes. Rev. https:\/\/doi.org\/10.1111\/obr.13128 (2020).","journal-title":"Obes. Rev."},{"key":"83110_CR30","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"83110_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"83110_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"83110_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"83110_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"83110_CR35","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso, D., Ngai, J., Speed, T. P. & Dudoit, S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol. 32, 896\u2013902 (2014).","journal-title":"Nat. Biotechnol."},{"key":"83110_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"Ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2009","unstructured":"Wickham, H. Ggplot2: Elegant Graphics for Data Analysis, viii, 212 p (Springer, New York, 2009)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83110-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:09:36Z","timestamp":1670022576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83110-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83110"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83110-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.01.20185884","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4243"}}